← Back to Search

Warning Labels on Cigarillo Packages for Smoking

N/A
Waitlist Available
Led By Jennifer Ross, PhD
Research Sponsored by Boston University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 2-4
Awards & highlights

Study Summary

This trial tests how warnings on cigarillo packages affect users' smoking intentions & behaviour. Participants will be asked to sort images & answer questions to see if warnings can reduce smoking.

Who is the study for?
This study is for current cigarillo smokers who have used cigarillos at least once a week in the past month. Participants will be recruited through Qualtrics Research Services.Check my eligibility
What is being tested?
The study tests how different warning formats on cigarillo packages affect users' intentions and behaviors. Over 6 weeks, participants sort ~20 packages by flavor while exposed to pictorial or text-only warnings, followed by a survey after 4 more weeks.See study design
What are the potential side effects?
Since this trial involves image sorting tasks and surveys without medical interventions, there are no direct physical side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intention to quit smoking cigarillos in the next 30 days at baseline
Intention to quit smoking cigarillos in the next 30 days at weeks 2-4
Secondary outcome measures
Cigarillo smoking behavior in the past week
Other outcome measures
Beliefs about harms associated with cigarillo smoking
Knowledge about harms associated with cigarillo smoking
Quitting self-efficacy based on anticipated success
+6 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Pictorial warningsExperimental Treatment1 Intervention
Participants randomized to this group will view pictorial cigarillo warnings.
Group II: FDA text-only warningsActive Control1 Intervention
Participants randomized to this group will view FDA text-only warnings.
Group III: Surgeon General text-only warningsActive Control1 Intervention
Participants randomized to this group will view Surgeon General text-only warnings.

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesOTHER
1,250 Previous Clinical Trials
1,006,678 Total Patients Enrolled
4 Trials studying Smoking
996 Patients Enrolled for Smoking
Brown UniversityOTHER
456 Previous Clinical Trials
557,756 Total Patients Enrolled
5 Trials studying Smoking
133 Patients Enrolled for Smoking
Boston UniversityLead Sponsor
458 Previous Clinical Trials
9,945,883 Total Patients Enrolled
1 Trials studying Smoking
60 Patients Enrolled for Smoking

Media Library

Pictorial warnings Clinical Trial Eligibility Overview. Trial Name: NCT05838378 — N/A
Smoking Research Study Groups: Pictorial warnings, FDA text-only warnings, Surgeon General text-only warnings
Smoking Clinical Trial 2023: Pictorial warnings Highlights & Side Effects. Trial Name: NCT05838378 — N/A
Pictorial warnings 2023 Treatment Timeline for Medical Study. Trial Name: NCT05838378 — N/A
~333 spots leftby Oct 2024